VVM

Versant Venture Management Portfolio holdings

AUM $82.1M
1-Year Est. Return 26.22%
This Quarter Est. Return
1 Year Est. Return
-26.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$60.2M
AUM Growth
-$26.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUE icon
1
Monte Rosa Therapeutics
GLUE
$621M
$26.2M 43.56%
5,652,922
CRSP icon
2
CRISPR Therapeutics
CRSP
$6.29B
$17M 28.18%
498,558
CTNM
3
Contineum Therapeutics
CTNM
$328M
$6.41M 10.64%
918,163
SKYE icon
4
Skye Bioscience
SKYE
$42.8M
$3.19M 5.3%
2,007,704
RPTX icon
5
Repare Therapeutics
RPTX
$78.6M
$2.61M 4.33%
2,646,657
TPST icon
6
Tempest Therapeutics
TPST
$45M
$2.59M 4.3%
269,773
ADVM icon
7
Adverum Biotechnologies
ADVM
$90M
$2.21M 3.68%
506,821